Novel dihydroxypyrrolidine derivatives as anti-cancer agents

The present invention provides new dihydroxypyrrolidine derivatives for use as medicaments. The compounds are useful in the treatment in cancer, in particular non-solid neoplasms.


Year:
2010
Other identifiers:
TTO: 6.0764.2
EPO Family ID: 40843358
Laboratories:




 Record created 2015-09-22, last modified 2018-01-28


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)